ADRIANNE DIMAURO: Open Payments
NPI 1861001729 · PALM BEACH GARDENS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$467 in 21 payments from 10 companies in 2025. Trend: 2023 $470 · 2024 $0 · 2025 $467
Food & beverage: $467
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $93 |
| BridgeBio Pharma, Inc. | 4 | $90 |
| AstraZeneca Pharmaceuticals LP | 4 | $76 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $64 |
| PFIZER INC. | 2 | $50 |
| AltaThera Pharmaceuticals LLC | 1 | $20 |
| Boston Scientific Corporation | 1 | $20 |
| Alnylam Pharmaceuticals Inc. | 1 | $20 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $14 |
Products named: Wegovy, Attruby, FARXIGA, Kerendia, VYNDAQEL, Sotalol Hydrochloride, WATCHMAN FLX, ONPATTRO.
Industry payments across FL — which companies pay providers there.
